NEW YORK, July 14 /PRNewswire-FirstCall/ -- Cardiogenesis Corp. (Other OTC: CGCP) announces the following Webcast:
What: | LHA Life Sciences & Med Tech Day 2010 Presentation | |
When: | July 20, 2010 @ 11:00 AM Eastern | |
Where: | ||
How: | Live over the Internet -- Simply log on to the web at the address above. | |
Contact: | Cheryl Palazzo, 212-838-3777, cpalazzo@lhai.com | |
If you are unable to participate during the live webcast, the call will be available for replay at http://www.investorcalendar.com/ClientPage.asp?ID=160338 or http://www.investorcalendar.com/
Cardiogenesis is a medical device company specializing in the therapies for the treatment of chronic cardiac ischemia. The company’s market leading Holmium:YAG laser system and disposable fiber-optic accessories are used to perform a FDA-cleared surgical procedure known as Transmyocardial Revascularization (TMR) to treat patients suffering from angina. Surgical products and accessories for the Cardiogenesis TMR procedure, which are marketed in the U.S. and around the world, have been shown to reduce angina and improve the quality of life in patients with coronary artery disease.
SOURCE Cardiogenesis Corp.
